50/50 mix Humalog Mix
Selected indexed studies
- Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes. (Ther Clin Risk Manag, 2015) [PMID:25565854]
- [Pharmaceutical development and clinical experiment of new antidiabetic drugs, premixed preparations of insulin lispro (Humalog Mix 25 and Humalog Mix 50) and intermediate-acting insulin lispro (Humalog N)]. (Nihon Yakurigaku Zasshi, 2005) [PMID:16205018]
- Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. (Int J Clin Pract, 2010) [PMID:20337752]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Effectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetes. (2015) pubmed
- [Pharmaceutical development and clinical experiment of new antidiabetic drugs, premixed preparations of insulin lispro (Humalog Mix 25 and Humalog Mix 50) and intermediate-acting insulin lispro (Humalog N)]. (2005) pubmed
- Comparison of Humalog Mix 50 with human insulin Mix 30 in type 2 diabetes patients during Ramadan. (2010) pubmed
- Continuous glucose monitoring with Humalog Mix 25 versus Humalog Mix 50, twice daily: a comparative pilot study -results from the Jikei-EValuation of insulin Lispro mixture on pharmacodynamics and glycemic VariancE (J-EVOLVE) study. (2010) pubmed
- Comparison of analog insulin mix 50:50 with human insulin mix 30:70 in persons with type 2 diabetes during Ramadan. (2019) pubmed
- Efficacy and safety of prandial premixed therapy using insulin lispro mix 50/50 3 times daily compared with progressive titration of insulin lispro mix 75/25 or biphasic insulin aspart 70/30 twice daily in patients with type 2 diabetes mellitus: a randomized, 16-week, open-label study. (2011) pubmed
- Use of 50/50 Premixed Insulin Analogs in Type 2 Diabetes: Systematic Review and Clinical Recommendations. (2017) pubmed
- A long-term analysis evaluating the cost-effectiveness of biphasic insulin lispro mix 75/25 and mix 50/50 versus long-acting basal insulin analogs in the United States. (2012) pubmed
- Intensifying insulin therapy in type 2 diabetes mellitus: dosing options for insulin analogue premixes. (2011) pubmed
- Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50. (2012) pubmed